CNS Pharmaceuticals Inc. (CNSP)
NASDAQ: CNSP
· Real-Time Price · USD
4.96
-1.07 (-17.74%)
At close: Aug 15, 2025, 3:59 PM
5.43
9.48%
After-hours: Aug 15, 2025, 07:47 PM EDT
CNS Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.3M | -3.18M | -5.61M | -2.53M | -3.54M | -5.38M | -4.52M | -4.02M | -4.93M | -5.5M | -3.42M | -3.57M | -3.15M | -2.8M | -3.81M | -3.81M | -3.61M |
Depreciation & Amortization | 1.1K | 985.00 | 751.00 | 752.00 | 818.00 | 953.00 | 899.00 | 1K | 1.28K | 2.38K | 2.79K | 3.21K | 3.38K | 3.49K | 3.37K | 3.21K | 3K |
Stock-Based Compensation | 62.37K | 129.9K | 271.78K | 234.34K | 202.93K | 232.68K | 194.76K | 289.67K | 290.31K | 289.72K | 289.72K | 286.84K | 336.69K | 316.91K | 506.65K | 469.61K | 430.68K |
Other Working Capital | 995.95K | -2.43M | -794.39K | 645.26K | 102.99K | 2.61M | 950.06K | -462.24K | 717.06K | 354.02K | 798.95K | -89.27K | 400.19K | -823.3K | 739.74K | -1.49M | -107.03K |
Other Non-Cash Items | n/a | n/a | -672.19K | n/a | -190 | -259 | 757.00 | -498.36K | 1.19M | 334.61K | 1.17K | 1.47K | n/a | 835.37K | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 498.36K | -1.19M | n/a | n/a | n/a | n/a | -835.37K | n/a | n/a | n/a |
Change in Working Capital | 995.95K | -2.43M | -794.39K | 645.26K | 149.13K | 2.61M | 950.06K | 327.79K | -184.24K | 2.57M | 1.31M | -88.1K | -265.48K | -762.05K | 1.31M | -1.66M | -128.33K |
Operating Cash Flow | -3.24M | -5.47M | -6.8M | -1.65M | -3.19M | -2.54M | -3.38M | -3.4M | -4.82M | -2.31M | -1.81M | -3.36M | -3.08M | -3.24M | -2M | -5M | -3.31M |
Capital Expenditures | n/a | -4.19K | -3 | 3.00 | -3 | -2.16K | -1.74K | n/a | n/a | n/a | -1.51K | -2.91K | n/a | -2.08K | n/a | n/a | -3.67K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 3.00 | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -4.19K | n/a | n/a | n/a | -2.16K | -1.74K | n/a | n/a | n/a | -1.51K | -2.91K | n/a | -2.08K | n/a | n/a | -3.67K |
Debt Repayment | -86.88K | -31.19K | -92.06K | -89.86K | -87.7K | -70.67K | -124.49K | -122.68K | -120.89K | -79.17K | -117.14K | -116.17K | -115.22K | -82.83K | -132.95K | -131.55K | -130.16K |
Common Stock Repurchased | -557 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 882.54K | -10K | -40K | -7.83K | 12.4K | 2.03M | n/a | n/a | n/a | 118.00 | n/a | n/a | 2.62K | n/a | n/a | n/a | n/a |
Financial Cash Flow | 9.83M | 4.96M | 12.28M | 2.33M | 3.46M | 2.18M | 8.36K | 2.57M | -120.28K | 5.33M | -117.14K | -116.17K | 10.51M | -82.83K | 3.44M | 808.31K | 347.43K |
Net Cash Flow | 6.59M | -511.75K | 5.48M | 676.33K | 266.5K | -360.83K | -3.37M | -831.28K | -4.94M | 3.03M | -1.93M | -3.48M | 7.44M | -3.32M | 1.44M | -4.19M | -2.96M |
Free Cash Flow | -3.24M | -5.48M | -6.8M | -1.65M | -3.19M | -2.54M | -3.38M | -3.4M | -4.82M | -2.31M | -1.81M | -3.37M | -3.08M | -3.24M | -2M | -5M | -3.31M |